An underground market for unapproved weight-loss medications is propelled by social media fitness personalities and sellers on communication apps, according to new investigations.
Investigational Treatment Acquiring Traction Online
Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are encouraged to message these accounts privately for source information, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Additionally, a flourishing market exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and claims of next-day British shipping. Vendors market the drug there before directing customers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Medical Experts Voice Worries
Nevertheless, doctors and pharmacists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could lead to users injecting products of unknown origin.
Some experts said the popularity for retatrutide could be connected to the increasing price of licensed weight loss products such as Mounjaro.
Legal Status and Implementation
Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that must not be promoted or supplied for human use under the British medical regulations.
Several content creators try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate medicines, advertising, and customer regulations, potentially leading to penalties, legal action or prison.
Platform Reaction and Material Removal
Based on the social media company, the service has removed violative material and banned related hashtags and query recommendations. The company stated it was committed to keeping the platform safe and allocating resources in strengthening enforcement strategies.
Digital Marketplace Activities
Research also found communities with up to 9,000 participants marketing retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up channels with numerous of members, populated with photos of slimming results, positive reviews and step-by-step instructions for preparing or injecting at residence.
Within minutes of joining one group, a vendor posted contact information, where most purchases take place. The seller provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about weight, health issues or previous experience.
Product Information and Costs
Inside these groups, posts display black plastic parcels with postal service labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at residence with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20mg. When questioned how much time a injector should last, vendors give contradictory answers varying between a several days to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for Telegram stated it regularly monitored harmful content on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting substances they cannot confirm. Although the research behind this drug is sound, these online products may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of an online medical service connected the surge in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.
Her team has already encountered individuals harmed by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”
Producer Position
A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company experimental product not yet approved … may expose patients to possibly serious medical dangers”.
